| Business Name: |
Libramonte & Malanum |
| Contact Person: |
Carmen Torres, Office Manager |
| Address: |
595 Flatbush Avenue, Brooklyn, New York 11225 |
| Phone Number: |
(718) 856-2800 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Founding Year: |
2001 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Coe Teresita MD - Brooklyn, NY 11225
Libramonte Edita C MD - Brooklyn, NY 11225
Olusanya Rufai MD - Brooklyn, NY 11225
Ny Diag - Brooklyn, NY 11225
Gordon Barbara F MD - Brooklyn, NY 11225
Simons Calvin MD - Brooklyn, NY 11225
Santos Jennie M MD - Brooklyn, NY 11225
Etienne Viviane Md - Brooklyn, NY 11225
Lambert Andrea MD - Brooklyn, NY 11225
Rosen Titelbaum Physician Service - Brooklyn, NY 11225
Malanum T MD - Brooklyn, NY 11225
Inner City Health Ministries I - Brooklyn, NY 11225
Lashley Eustace MD - Brooklyn, NY 11225
Smith Alford A MD - Brooklyn, NY 11225
Rankin - Brooklyn, NY 11225
D'Augustine Jean MD - Brooklyn, NY 11225
Jean B Tropnas Md - Brooklyn, NY 11225
F S Folks Md - Brooklyn, NY 11225
Torrijos Emma B MD - Brooklyn, NY 11225
Rimpel Bernard MD - Brooklyn, NY 11225
|
The company Libramonte & Malanum provides B2C services in the form of Doctors from its single location in New York.
1 to 4 employees work for Libramonte & Malanum, and the business now earns $500.000 to $999.999 per annum.
Libramonte & Malanum was launched in 2001 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Libramonte & Malanum, please call Carmen Torres, Office Manager with the phone number (718) 856-2800 or visit its single location at 595 Flatbush Avenue in Brooklyn, New York 11225.
The location of the single location can also be found using the coordinates 40.658916,-73.960379.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.